Aberrant levels of proteins conferring resistance to TRAIL in a variety of cancer cells rely at least in part on the activation of anti-apoptotic signal transduction pathways, such as mitogen-activated protein kinase (MAPK), NF-κB, and STAT3 [105]. The gene discussed is NFKB1; the disease is cancer.